InsiderClue
← All stocks

Vir Biotechnology, Inc.

VIR Scheduled selling only
CIK 0001706431 #2232 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$21.00M
$20.59M on a plan · $413.37K straight out of an exercise
Sold at will
$0.00
0 of 52 sales
Net
−$21.00M
$0.00 against sales at will

By person

17 insiders · 52 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SVF Endurance (Cayman) Ltd entity
10% owner
—
$17.85M (21) scheduled
−$17.85M
13,728,924
8.11%
$129.74M
−17.7%
SATO VICKI L
Director
—
$1.73M (11) scheduled
−$1.73M
1,078,391
0.6373%
$10.19M
−18.5%
De Backer Marianne
President and CEO
—
$946.96K (3) scheduled
−$946.96K
1,001,263
0.5917%
$9.46M
+47.6%
de Verneuil Vanina
EVP, General Counsel, Corp Sec
—
$217.68K (5) scheduled
−$217.68K
112,982
0.0668%
$1.07M
+64.4%
Sabatini Brent
SVP, Chief Accounting Officer
—
$113.09K (5) scheduled
−$113.09K
61,902
0.0366%
$584.97K
+88.1%
O'Byrne Jason
EVP & Chief Financial Officer
—
$68.93K (3) scheduled
−$68.93K
162,615
0.0961%
$1.54M
+5,084%
Eisner Mark
EVP and Chief Medical Officer
—
$49.52K (3) scheduled
−$49.52K
154,024
0.0910%
$1.46M
+105.4%
Napolitano Janet
Director
—
$30.24K (1) scheduled
−$30.24K
21,216
0.0125%
$200.49K
+82.6%
SCANGOS GEORGE A
Director
—
—
—
1,849,969
1.09%
$17.48M
−1.1%
MORE ROBERT J
Director
—
—
—
558,573
0.3301%
$5.28M
+2.9%
HANLY ANN M.
EVP & Chief Technology Officer
—
—
—
117,901
0.0697%
$1.11M
−10.7%
Sigal Charles Elliott
Director
—
—
—
39,806
0.0235%
$376.17K
+67.2%
Hatfield Jeffrey S.
Director
—
—
—
39,806
0.0235%
$376.17K
+67.2%
Farid Ramy
Director
—
—
—
32,000
0.0189%
$302.40K
+100.0%
BISCHOFBERGER NORBERT W
Director
—
—
—
32,000
0.0189%
$302.40K
+100.0%
Ramasastry Saira
Director
—
—
—
22,619
0.0134%
$213.75K
+54.7%
Coughlin Timothy
Director
—
—
—
16,000
0.0095%
$151.20K
—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 48
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 50
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,069,441
History held since 10 Oct 2019